Human Genetics Market Size

Human Genetics Market Growth Projections and Opportunities

Human genetics encompasses the study of the human genome and the transmission of genes from parents to children. It involves applications such as diagnosing and treating inherited genetic disorders through gene expression, cytogenetics, mutation detection, and genetic screening. The global human genetics market is witnessing growth due to the increased adoption of genetic testing and a rise in the incidences of genetic diseases and cancer. However, challenges like the high cost of genetic testing and a shortage of skilled genetic counselors may impede market growth. Nevertheless, the ongoing technological advancements in genetic testing and the integration of genetic data across the healthcare sector present promising opportunities for future market growth.
Genetic testing involves the examination of an individual's DNA, which has undergone significant changes over generations due to evolutionary and lifestyle factors. Some of these changes have provided evolutionary advantages, while others have led to diseases and disorders. In recent decades, personalized healthcare based on a patient's genetic code has gained prominence in medical research, addressing conditions from cancer to cardiovascular diseases. These factors contribute to the increasing adoption of human genetics for applications such as wellness, preventive medicine, and diagnostics and treatment.

In the domain of diagnostics and treatment, the human genetics market witnessed significant growth in 2020 and is expected to exhibit the highest Compound Annual Growth Rate (CAGR) during the forecast period. Healthcare providers utilize genetic testing for diagnosing genetic conditions, employing various approaches, including physical examinations, personal medical histories, family health histories, and laboratory tests. Genetic testing is categorized into different types, such as Noninvasive Prenatal Testing (NIPT), carrier testing, thrombophilia testing, karyotype testing, and Next-Generation Sequencing (NGS), addressing various genetic conditions. This diversification contributes to the segment's growth. The increasing number of initiatives by both public and private organizations to promote genetic testing for disease prevention further propels overall growth. For example, Ancestry launched AncestryHealth powered by NGS in August 2020, offering genetic screening for various health conditions like heart disease, colon cancer, blood cancer, and blood disorders.

The NGS segment dominated the market in 2020 and is anticipated to exhibit the highest CAGR during the forecast period.